RERCX
Price
$63.17
Change
-$0.27 (-0.43%)
Updated
Oct 17 closing price
Net Assets
137.06B
SGQCX
Price
$42.96
Change
-$0.03 (-0.07%)
Updated
Oct 17 closing price
Net Assets
481.5M
Interact to see
Advertisement

RERCX vs SGQCX

Header iconRERCX vs SGQCX Comparison
Open Charts RERCX vs SGQCXBanner chart's image
American Funds EUPAC R3
Price$63.17
Change-$0.27 (-0.43%)
VolumeN/A
Net Assets137.06B
DWS International Growth C
Price$42.96
Change-$0.03 (-0.07%)
VolumeN/A
Net Assets481.5M
RERCX vs SGQCX Comparison Chart in %
View a ticker or compare two or three
VS
RERCX vs. SGQCX commentary
Oct 19, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is RERCX is a Buy and SGQCX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RERCX has more cash in the bank: 137B vs. SGQCX (482M). RERCX pays higher dividends than SGQCX: RERCX (0.47) vs SGQCX (0.38). RERCX was incepted earlier than SGQCX: RERCX (23 years) vs SGQCX (24 years). SGQCX (2.17) is less costly to investors than RERCX (1.12). RERCX is a more actively managed with annual turnover of: 35.00 vs. SGQCX (7.00). RERCX has a lower initial minimum investment than SGQCX: RERCX (250) vs SGQCX (1000). RERCX annual gain was more profitable for investors over the last year : 10.58 vs. SGQCX (9.58). SGQCX (12.75) and RERCX (12.22) have equivalent 5 years return.
RERCXSGQCXRERCX / SGQCX
Total Expense Ratio1.121.8760%
Annual Report Gross Expense Ratio1.122.1752%
Fund Existence23 years24 years-
Gain YTD21.10817.345122%
Front LoadN/AN/A-
Min. Initial Investment250100025%
Min. Initial Investment IRAN/AN/A-
Net Assets137B482M28,423%
Annual Yield % from dividends0.470.38123%
Returns for 1 year10.589.58110%
Returns for 3 years47.4750.5894%
Returns for 5 years12.2212.7596%
Returns for 10 years39.9059.0568%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ADAP0.20N/A
+2.51%
Adaptimmune Therapeutics plc
HALO67.030.15
+0.22%
Halozyme Therapeutics
FCNCP22.25-0.09
-0.40%
First Citizens BancShares
RZLV4.87-0.17
-3.37%
Rezolve AI PLC
RXT1.42-0.05
-3.40%
Rackspace Technology